Edition:
United States

Peregrine Pharmaceuticals Inc (PPHM.OQ)

PPHM.OQ on NASDAQ Stock Exchange Capital Market

0.31USD
11:36am EST
Change (% chg)

$0.01 (+2.52%)
Prev Close
$0.31
Open
$0.34
Day's High
$0.34
Day's Low
$0.31
Volume
90,168
Avg. Vol
174,560
52-wk High
$1.30
52-wk Low
$0.29

Select another date:

Mon, Oct 10 2016

BRIEF-Peregrine Pharmaceuticals reports top-line data from phase III SUNRISE trial of Bavituximab

* Press release - Peregrine Pharmaceuticals reports top-line and initial biomarker data from phase III SUNRISE trial of Bavituximab in oral presentation at European Society for Medical Oncology (ESMO) 2016 congress

BRIEF-Peregrine Pharmaceuticals Q4 loss per share $0.05

* Peregrine pharmaceuticals reports financial results for quarter and fiscal year ended april 30, 2016 and recent developments

Select another date: